Continued reliance on Windows XP in physician practices may threaten data security

Continued reliance on windows XP may threaten data security

(HealthDay)—Physicians who use Windows XP in their practices may be affected by Microsoft's recent discontinuation of support for the program, according to an article published April 8 in Medical Economics.

The author of the article, Derek Kosiorek, writes that continued use of this non-supported operating system may expose a practice to privacy risks. Without support, the product may not be secure from new forms of hacking or . Such breaches pose a risk to protected patient information and may violate the Health Insurance Portability and Accountability Act (HIPAA).

To maintain security, Kosiorek suggests physician practices ensure that anti-virus software is up to date and still works on XP and that a firewall is in place to protect the network. In evaluating operating systems to replace XP it is recommended that practices ensure all software works on newer operating systems to ensure continued functionality. Then, practices can evaluate replacing the computer, upgrading the operating system on the existing computer, or run software off a server (creating a "virtual desktop connection").

"The most important consideration that practices will face is to ensure the integrity and security of the patient data," Kosiorek writes.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Face transplants change lives, identity

43 minutes ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments